Gagnon Advisors LLC Takes $3.35 Million Position in Aspen Aerogels, Inc. $ASPN

Gagnon Advisors LLC purchased a new stake in Aspen Aerogels, Inc. (NYSE:ASPNFree Report) during the 2nd quarter, HoldingsChannel.com reports. The institutional investor purchased 565,570 shares of the construction company’s stock, valued at approximately $3,348,000. Aspen Aerogels accounts for about 2.2% of Gagnon Advisors LLC’s investment portfolio, making the stock its 20th biggest holding.

Several other hedge funds and other institutional investors also recently modified their holdings of ASPN. Acadian Asset Management LLC bought a new position in shares of Aspen Aerogels in the 1st quarter valued at $43,000. Banque Cantonale Vaudoise bought a new position in shares of Aspen Aerogels in the 1st quarter valued at $45,000. Exchange Traded Concepts LLC grew its position in Aspen Aerogels by 460.4% during the 1st quarter. Exchange Traded Concepts LLC now owns 7,436 shares of the construction company’s stock worth $48,000 after acquiring an additional 6,109 shares during the last quarter. CWM LLC grew its position in Aspen Aerogels by 2,137.9% during the 1st quarter. CWM LLC now owns 8,325 shares of the construction company’s stock worth $53,000 after acquiring an additional 7,953 shares during the last quarter. Finally, Teacher Retirement System of Texas bought a new stake in Aspen Aerogels during the 1st quarter worth $65,000. Institutional investors own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the company. Barclays lowered Aspen Aerogels from an “equal weight” rating to an “underweight” rating and boosted their price objective for the stock from $7.00 to $16.00 in a research report on Monday, August 11th. Canaccord Genuity Group reduced their price objective on Aspen Aerogels from $11.00 to $10.00 and set a “buy” rating on the stock in a research report on Friday, August 8th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Aspen Aerogels in a research report on Saturday, September 27th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Aspen Aerogels has an average rating of “Moderate Buy” and a consensus target price of $19.50.

View Our Latest Report on ASPN

Aspen Aerogels Trading Down 7.1%

Shares of ASPN stock opened at $8.09 on Wednesday. The stock has a market cap of $665.88 million, a price-to-earnings ratio of -2.12 and a beta of 2.80. The stock has a 50-day moving average of $7.13 and a 200-day moving average of $6.46. The company has a current ratio of 3.98, a quick ratio of 3.31 and a debt-to-equity ratio of 0.34. Aspen Aerogels, Inc. has a 1-year low of $4.16 and a 1-year high of $26.90.

Aspen Aerogels (NYSE:ASPNGet Free Report) last issued its quarterly earnings results on Thursday, August 7th. The construction company reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.12) by $0.08. The company had revenue of $78.02 million during the quarter, compared to analysts’ expectations of $72.53 million. Aspen Aerogels had a positive return on equity of 2.92% and a negative net margin of 78.53%.The business’s quarterly revenue was down 33.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.21 earnings per share. Aspen Aerogels has set its FY 2025 guidance at -3.860–3.730 EPS. On average, equities research analysts forecast that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current year.

Insider Buying and Selling at Aspen Aerogels

In other news, CAO Santhosh P. Daniel sold 4,410 shares of the stock in a transaction dated Tuesday, August 12th. The stock was sold at an average price of $7.31, for a total value of $32,237.10. Following the completion of the sale, the chief accounting officer owned 19,879 shares of the company’s stock, valued at approximately $145,315.49. This represents a 18.16% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 3.40% of the company’s stock.

Aspen Aerogels Profile

(Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Featured Articles

Want to see what other hedge funds are holding ASPN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aspen Aerogels, Inc. (NYSE:ASPNFree Report).

Institutional Ownership by Quarter for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.